SAB BIOTHERAPEUTICS INC (SABS) Stock Cash Flow
USA - NASDAQ:SABS - US78397T2024 - Common Stock
2.26 USD
-0.22 (-8.87%)
2.24 USD
-0.02 (-0.88%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.06M | -34.11M | -42.19M | -18.74M | -17.14M | |||
| Depreciation Amortization | 3.31M | 4.79M | 3.65M | 3.17M | 1.49M | |||
| Change In Working Capital | 2.22M | -2.30M | 2.33M | -238.00K | 11.68M | |||
| Interest Paid | 359.70K | 374.00K | 245.00K | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | 757.50K | -2.68M | 11.10M | -7.65M | 5.96M | |||
| OPERATING CASH FLOW | -30.77M | -34.29M | -25.12M | -23.46M | 1.99M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -337.30K | -197.00K | -2.17M | -10.94M | |||
| Other Investing Activity | 18.20M | -11.63M | 44.00K | 76.00K | 0.00 | |||
| INVESTING CASH FLOW | 18.05M | -11.96M | -153.00K | -2.09M | -10.94M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -753.00K | -907.00K | -390.00K | -1.19M | 1.54M | |||
| Stock Issued/Repurchased | N/A | 20.40K | 67.16M | 2.24M | 34.35M | |||
| Other Financing Activity | -52.00K | -286.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -804.90K | -1.17M | 66.77M | 1.05M | 35.89M | |||
| Exchange Rate Effect | -19.30K | -241.20K | 18.00K | N/A | N/A | |||
| CHANGE IN CASH | -13.55M | -47.67M | 41.52M | -24.50M | 26.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.77M | -34.29M | -25.12M | -23.46M | 1.99M | |||
| Capital Expenditure | N/A | -337.30K | -197.00K | -2.17M | -10.94M | |||
| FREE CASH FLOW | -30.93M | -34.63M | -25.32M | -25.63M | -8.96M | |||
All data in USD